Happy Birthday to Rolling Stones and Faces guitarist Ron Wood who turns 74 today (June 1st)!!! Back in April, Ron Wood revealed that during the pandemic he's battled back from another bout of cancer. The guitarist told Britain's The Sun: "I've had cancer two different ways now. I had lung cancer in 2017 and I had small-cell more recently that I fought in the last lockdown. I came through with the all-clear." Small-cell carcinoma is a fast-growing type of lung cancer commonly caused by smoking. Ron Wood spoke about what he's been plotting while on lockdown: "I'm just as busy as ever but nowadays I can remember what I'm doing. The music is still throbbing away. I've got a new album recorded at the Royal Albert Hall with Mick Taylor and my band a tribute to Jimmy Reed called Mr. Luck. I used to never stop. It must have been relentless to be around me, just crazy the stuff I did. I was erratic but none of my enthusiasm has gone." Out
When Derren started the fundraiser, he only expected to raise around £400, so to have raised nearly 10 times that is a huge achievement.
Speaking about his month of running, Derren said: I certainly did not find it easy. It was all right for the first six days and then I got injured and had to go to the physio three times. I had to do some run-walking to get my calf back to full fitness and then in the end I managed to run little and often to ensure I finished the challenge.
Running 50 miles in a month is not the only way that Derren has been trying to raise awareness about prostate cancer - he has also been very active on social media, particularly twitter, by sharing his experiences in order to help other men.
Scientists propose new strategies to find drugs that neutralize critical enzymes
May 26 2021
Scientists from the University of Bath explore racemases and propose strategies for finding drugs that target these important enzymes.
The active site of alanine racemase, a key antibacterial target. Image Credit: University of Bath
Academics from the University of Bath explore racemases – an important type of enzyme that is linked to certain cancers and other life-threatening diseases while also being critical to cell function – in a paper published in the prestigious journal
Chemical Society Reviews. The scientists also propose new strategies for finding drugs that neutralize these enzymes.
Credit: University of Bath
Scientists from the UK s University of Bath explore racemases - an important type of enzyme that is linked to certain cancers and other life-threatening diseases while also being critical to cell function - in a paper published in the prestigious journal
Chemical Society Reviews. The scientists also propose new strategies for finding drugs that neutralise these enzymes.
Many racemases and epimerases perform vital roles in human and animal cells, and in disease-causing organisms. They facilitate proper nerve function, the degradation of toxic substances, the formation of bacterial cell walls and the conversion of certain drugs into their active form (the best known conversion is seen with ibuprofen, which is taken as a mixture of isomers and converted in the liver to the active S-isomer). But while normal levels of racemase and epimerase function are generally beneficial, increased levels can be harmful. Because of this, there is considerable interest in